Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
GPGI · NYSE · United States · Finance Services
In shortGPGI, Inc. is loss-making.
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it. Bank or insurer: tests that do not apply to them are left out.
| Operating marginShare of each sale left after running the business, before interest and tax. | -23.0% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -227.3% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -272.8% | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -38.2% | n/a |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 4 of 5 | n/a |
Weight in the score: 20%
| Profitable years (last 5) | 3 of 5 | 60/100 |
|---|---|---|
| Years of revenue decline (last 5) | 1 of 5 | 67/100 |
| Revenue growth volatility | 47.3% | 0/100 |
| Operating margin volatility | 23.4% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -45.9% | 0/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
2 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 268 | 378 | 391 | 421 | 60 |
| Cost of revenue | 123 | 159 | 182 | 201 | 31 |
| Gross profit | 145 | 220 | 209 | 219 | 29 |
| Research & development | 2.7 | 6.7 | 6.8 | 7.4 | 1.3 |
| Operating income | 81 | 115 | 119 | 108 | (14) |
| Interest expense | 12 | 21 | 28 | 20 | 1.7 |
| Pre-tax income | 83 | 136 | 117 | (81) | (226) |
| Income tax | (0.9) | 4.4 | 4.6 | 2.2 | 39 |
| Net income | 3.2 | 19 | 19 | (54) | (136) |
| Diluted EPS | $0.12 | $1.13 | $0.96 | −$1.22 | −$1.23 |
| Diluted shares (millions) | 95 | 33 | 35 | 44 | 111 |
2 older years available with the 10-year history. Essential plan, from €8.25/month →
Not computed: the model does not apply to banks and insurers.
3/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 6, 2026